{"downloaded": true, "htmlmade": false, "full": {"id": "30230266", "source": "MED", "pmid": "30230266", "pmcid": "PMC6204595", "fullTextIdList": {"fullTextId": "PMC6204595"}, "doi": "10.1002/jcsm.12316", "title": "Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty.", "authorString": "Winkler T, Perka C, von Roth P, Agres AN, Plage H, Preininger B, Pumberger M, Geissler S, Hagai EL, Ofir R, Pinzur L, Eyal E, Stoltenburg-Didinger G, Meisel C, Consentius C, Streitz M, Reinke P, Duda GN, Volk HD.", "authorList": {"author": [{"fullName": "Winkler T", "firstName": "Tobias", "lastName": "Winkler", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Perka C", "firstName": "Carsten", "lastName": "Perka", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "von Roth P", "firstName": "Philipp", "lastName": "von Roth", "initials": "P", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Agres AN", "firstName": "Alison N", "lastName": "Agres", "initials": "AN", "authorId": {"@type": "ORCID", "#text": "0000-0002-9620-5689"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Plage H", "firstName": "Henning", "lastName": "Plage", "initials": "H", "authorId": {"@type": "ORCID", "#text": "0000-0002-7680-1870"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}}}, {"fullName": "Preininger B", "firstName": "Bernd", "lastName": "Preininger", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}}}, {"fullName": "Pumberger M", "firstName": "Matthias", "lastName": "Pumberger", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Geissler S", "firstName": "Sven", "lastName": "Geissler", "initials": "S", "authorId": {"@type": "ORCID", "#text": "0000-0002-8750-6324"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Hagai EL", "firstName": "Esther Lukasiewicz", "lastName": "Hagai", "initials": "EL", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Pluristem Ltd, Haifa, Israel."}}}, {"fullName": "Ofir R", "firstName": "Racheli", "lastName": "Ofir", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Pluristem Ltd, Haifa, Israel."}}}, {"fullName": "Pinzur L", "firstName": "Lena", "lastName": "Pinzur", "initials": "L", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Pluristem Ltd, Haifa, Israel."}}}, {"fullName": "Eyal E", "firstName": "Eli", "lastName": "Eyal", "initials": "E", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Pluristem Ltd, Haifa, Israel."}}}, {"fullName": "Stoltenburg-Didinger G", "firstName": "Gisela", "lastName": "Stoltenburg-Didinger", "initials": "G", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Institute of Cell Biology and Neurobiology, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}}}, {"fullName": "Meisel C", "firstName": "Christian", "lastName": "Meisel", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Institute for Medical Immunology, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}}}, {"fullName": "Consentius C", "firstName": "Christine", "lastName": "Consentius", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Streitz M", "firstName": "Mathias", "lastName": "Streitz", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Institute for Medical Immunology, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Reinke P", "firstName": "Petra", "lastName": "Reinke", "initials": "P", "authorId": {"@type": "ORCID", "#text": "0000-0003-0771-4375"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Clinic of Nephrology and Internal Intensive Care Medicine, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Duda GN", "firstName": "Georg N", "lastName": "Duda", "initials": "GN", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}, {"fullName": "Volk HD", "firstName": "Hans-Dieter", "lastName": "Volk", "initials": "HD", "authorId": {"@type": "ORCID", "#text": "0000-0002-7743-6668"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Berlin-Brandenburg Center for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Berlin-Brandenburg School for Regenerative Therapies, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}, {"affiliation": "Institute for Medical Immunology, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany."}]}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0002-7680-1870"}, {"@type": "ORCID", "#text": "0000-0002-7743-6668"}, {"@type": "ORCID", "#text": "0000-0002-8750-6324"}, {"@type": "ORCID", "#text": "0000-0002-9620-5689"}, {"@type": "ORCID", "#text": "0000-0003-0771-4375"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "5", "volume": "9", "journalIssueId": "2742212", "dateOfPublication": "2018 Oct", "monthOfPublication": "10", "yearOfPublication": "2018", "printPublicationDate": "2018-10-01", "journal": {"title": "Journal of cachexia, sarcopenia and muscle", "ISOAbbreviation": "J Cachexia Sarcopenia Muscle", "medlineAbbreviation": "J Cachexia Sarcopenia Muscle", "NLMid": "101552883", "ISSN": "2190-5991", "ESSN": "2190-6009"}}, "pubYear": "2018", "pageInfo": "880-897", "abstractText": "<h4>Background</h4>No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite their high frequency and associated functional deficits. We sought to address surgical trauma-related muscle injuries using local intraoperative application of allogeneic placenta-derived, mesenchymal-like adherent cells (PLX-PAD), using hip arthroplasty as a standardized injury model, because of the high regenerative and immunomodulatory potency of this cell type.<h4>Methods</h4>Our pilot phase I/IIa study was prospective, randomized, double blind, and placebo-controlled. Twenty patients undergoing hip arthroplasty via a direct lateral approach received an injection of 3.0 \u00d7 10<sup>8</sup> (300 M, n = 6) or 1.5 \u00d7 10<sup>8</sup> (150\u00a0M, n\u00a0=\u00a07) PLX-PAD or a placebo (n\u00a0=\u00a07) into the injured gluteus medius muscles.<h4>Results</h4>We did not observe any relevant PLX-PAD-related adverse events at the 2-year follow-up. Improved gluteus medius strength was noted as early as Week 6 in the treatment-groups. Surprisingly, until Week 26, the low-dose group outperformed the high-dose group and reached significantly improved strength compared with placebo [150\u00a0M vs. placebo: P\u00a0=\u00a00.007 (baseline adjusted; 95% confidence interval 7.6, 43.9); preoperative baseline values mean \u00b1 SE: placebo: 24.4\u00a0\u00b1\u00a06.7\u00a0Nm, 150\u00a0M: 27.3\u00a0\u00b1\u00a05.6 Nm], mirrored by an increase in muscle volume [150\u00a0M vs. placebo: P\u00a0=\u00a00.004 (baseline adjusted; 95% confidence interval 6.0, 30.0); preoperative baseline values GM volume: placebo: 211.9\u00a0\u00b1\u00a015.3 cm<sup>3</sup> , 150\u00a0M: 237.4\u00a0\u00b1 27.2\u00a0cm<sup>3</sup> ]. Histology indicated accelerated healing after cell therapy. Biomarker studies revealed that low-dose treatment reduced the surgery-related immunological stress reaction more than high-dose treatment (exemplarily: CD16+ NK cells: Day 1 P\u00a0=\u00a00.06 vs. placebo, P\u00a0=\u00a00.07 vs. 150\u00a0M; CD4+ T-cells: Day 1 P\u00a0=\u00a00.04 vs. placebo, P\u00a0=\u00a00.08 vs. 150\u00a0M). Signs of late-onset immune reactivity after high-dose treatment corresponded to reduced functional improvement.<h4>Conclusions</h4>Allogeneic PLX-PAD therapy improved strength and volume of injured skeletal muscle with a reasonable safety profile. Outcomes could be positively correlated with the modulation of early postoperative stress-related immunological reactions.", "affiliation": "Center for Musculoskeletal Surgery and Julius Wolff Institute, Charit\u00e9-Universitaetsmedizin Berlin, Berlin, Germany.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["Clinical Trial, Phase II", "Research Support, Non-U.S. Gov't", "research-article", "Clinical Trial, Phase I", "Randomized Controlled Trial", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Muscle, Skeletal", "meshQualifierList": {"meshQualifier": {"abbreviation": "PH", "qualifierName": "physiology", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Mesenchymal Stem Cells", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Placenta", "meshQualifierList": {"meshQualifier": {"abbreviation": "CY", "qualifierName": "cytology", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Magnetic Resonance Imaging"}, {"majorTopic_YN": "Y", "descriptorName": "Arthroplasty, Replacement, Hip"}, {"majorTopic_YN": "N", "descriptorName": "Regeneration"}, {"majorTopic_YN": "N", "descriptorName": "Immunity"}, {"majorTopic_YN": "N", "descriptorName": "Pregnancy"}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "Y", "descriptorName": "Immunomodulation"}, {"majorTopic_YN": "N", "descriptorName": "Biomechanical Phenomena"}, {"majorTopic_YN": "N", "descriptorName": "Biomarkers"}]}, "keywordList": {"keyword": ["Immunomodulation", "Cell therapy", "Biomarkers", "Muscle Regeneration", "Mesenchymal Stromal Cells", "Muscle Injury"]}, "chemicalList": {"chemical": {"name": "Biomarkers", "registryNumber": "0"}}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1002/jcsm.12316"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6204595"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6204595?pdf=render"}]}, "commentCorrectionList": {"commentCorrection": {"id": "PPR14491", "source": "PPR", "type": "Preprint in", "note": "CrossRef Pre-print loader", "orderIn": "10002"}}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "20", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "nct"}, "dateOfCompletion": "2019-09-11", "dateOfCreation": "2018-09-20", "firstIndexDate": "2018-09-19", "fullTextReceivedDate": "2020-07-11", "dateOfRevision": "2021-01-09", "electronicPublicationDate": "2018-09-19", "firstPublicationDate": "2018-09-19"}, "htmllinks": "https://europepmc.org/articles/PMC6204595", "abstract": "<h4>Background</h4>No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite their high frequency and associated functional deficits. We sought to address surgical trauma-related muscle injuries using local intraoperative application of allogeneic placenta-derived, mesenchymal-like adherent cells (PLX-PAD), using hip arthroplasty as a standardized injury model, because of the high regenerative and immunomodulatory potency of this cell type.<h4>Methods</h4>Our pilot phase I/IIa study was prospective, randomized, double blind, and placebo-controlled. Twenty patients undergoing hip arthroplasty via a direct lateral approach received an injection of 3.0 \u00d7 10<sup>8</sup> (300 M, n = 6) or 1.5 \u00d7 10<sup>8</sup> (150\u00a0M, n\u00a0=\u00a07) PLX-PAD or a placebo (n\u00a0=\u00a07) into the injured gluteus medius muscles.<h4>Results</h4>We did not observe any relevant PLX-PAD-related adverse events at the 2-year follow-up. Improved gluteus medius strength was noted as early as Week 6 in the treatment-groups. Surprisingly, until Week 26, the low-dose group outperformed the high-dose group and reached significantly improved strength compared with placebo [150\u00a0M vs. placebo: P\u00a0=\u00a00.007 (baseline adjusted; 95% confidence interval 7.6, 43.9); preoperative baseline values mean \u00b1 SE: placebo: 24.4\u00a0\u00b1\u00a06.7\u00a0Nm, 150\u00a0M: 27.3\u00a0\u00b1\u00a05.6 Nm], mirrored by an increase in muscle volume [150\u00a0M vs. placebo: P\u00a0=\u00a00.004 (baseline adjusted; 95% confidence interval 6.0, 30.0); preoperative baseline values GM volume: placebo: 211.9\u00a0\u00b1\u00a015.3 cm<sup>3</sup> , 150\u00a0M: 237.4\u00a0\u00b1 27.2\u00a0cm<sup>3</sup> ]. Histology indicated accelerated healing after cell therapy. Biomarker studies revealed that low-dose treatment reduced the surgery-related immunological stress reaction more than high-dose treatment (exemplarily: CD16+ NK cells: Day 1 P\u00a0=\u00a00.06 vs. placebo, P\u00a0=\u00a00.07 vs. 150\u00a0M; CD4+ T-cells: Day 1 P\u00a0=\u00a00.04 vs. placebo, P\u00a0=\u00a00.08 vs. 150\u00a0M). Signs of late-onset immune reactivity after high-dose treatment corresponded to reduced functional improvement.<h4>Conclusions</h4>Allogeneic PLX-PAD therapy improved strength and volume of injured skeletal muscle with a reasonable safety profile. Outcomes could be positively correlated with the modulation of early postoperative stress-related immunological reactions.", "Keywords": ["Immunomodulation", "Cell therapy", "Biomarkers", "Muscle Regeneration", "Mesenchymal Stromal Cells", "Muscle Injury"], "pdflinks": "https://europepmc.org/articles/PMC6204595?pdf=render", "journaltitle": "Journal of cachexia, sarcopenia and muscle", "authorinfo": ["Winkler T", "Perka C", "von Roth P", "Agres AN", "Plage H", "Preininger B", "Pumberger M", "Geissler S", "Hagai EL", "Ofir R", "Pinzur L", "Eyal E", "Stoltenburg-Didinger G", "Meisel C", "Consentius C", "Streitz M", "Reinke P", "Duda GN", "Volk HD"], "title": "Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty."}